COMMUNIQUÉS West-GlobeNewswire

-
The Ensign Group, Inc. Declares Quarterly Dividend of $0.06 Per Share
14/06/2024 -
Gain Therapeutics Announces Proposed Public Offering
13/06/2024 -
Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress
13/06/2024 -
Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update
13/06/2024 -
Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
13/06/2024 -
QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs
13/06/2024 -
Beyond Air® Appoints David Webster as Chief Commercial Officer
13/06/2024 -
Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors
13/06/2024 -
Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors
13/06/2024 -
Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Study (SOL-R) in wet AMD at Investor Day, Along with Positive 48-week Data from HELIOS NPDR Study
13/06/2024 -
Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Directors
13/06/2024 -
Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
13/06/2024 -
IN8bio Presents Positive Data Demonstrating Durable 1-year Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100
13/06/2024 -
Voyager Therapeutics to Present at Multiple Virtual Investor Conferences
13/06/2024 -
Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders
13/06/2024 -
Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)
13/06/2024 -
From Awareness to Action on Global Fatty Liver Day
13/06/2024 -
ACTG Announces Launch of its First HIV Cure Clinical Trial in Africa
13/06/2024 -
Noom Announces Strategic Expansion of Executive Team with Key Leadership Appointments
13/06/2024
Pages